1-9 of 9
Kathryn Flynn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib as initial therapy with addition of lower dose tyrosine kinase inhibitors (TKIs) for patients with chronic myeloid leukemia who do not achieve optimal response or a deep molecular remission

Free
James Thompson, Lisa Rein, Michael Mauro, Srinivas Tantravahi, Jay Yang, Arielle Baim, Sonia Maldonado-Schmidt, Claire Olig, Kathryn Flynn, Yan Gao, Jerald Radich, Ehab Atallah, Jorge Cortes
Journal: Blood
Blood (2025) 146 (Supplement 1): 7311.
https://doi.org/10.1182/blood-2025-7311
Published: 2025
Journal Articles

Real world outcomes of patients with CML-CP treated with tyrosine kinase inhibitors from the h. jean khoury cure CML consortium (HJKC3)

Free
Ehab Atallah, Emily Giever, Jorge Cortes, Ryan Conrardy, Lisa Rein, Arielle Baim, Idayat Akinola, James Thompson, Yan Gao, Richard Larson, Ravi Bhatia, B. Douglas Smith, Kathryn Flynn
Journal: Blood
Blood (2025) 146 (Supplement 1): 2844.
https://doi.org/10.1182/blood-2025-2844
Published: 2025
Journal Articles

Treatment free remission after asciminib (ABL001) based therapy in chronic Phase chronic myeloid leukemia (CP-CML) patients who relapsed after a prior attempt at TKI discontinuation-h jean khoury cure CML consortium study HJKC3-0003

Free
Michael Mauro, Lisa Rein, Jay Yang, Srinivas Tantravahi, Sonia Maldonado-Schmidt, Claire Olig, Alexander Hinman, Arielle Baim, Jerald Radich, Kathryn Flynn, Ehab Atallah
Journal: Blood
Blood (2025) 146 (Supplement 1): 7293.
https://doi.org/10.1182/blood-2025-7293
Published: 2025
Journal Articles

Asciminib (ASC) demonstrates continued improvement in patient-reported outcomes (PROs) vs investigator-selected tyrosine kinase inhibitors (IS-TKIs) in newly diagnosed chronic myeloid leukemia (CML): ASC4FIRST week 96 analysis

Free
Jorge Cortes, Andreas Hochhaus, Kathryn Flynn, Felice Bombaci, Ghayas Issa, Richard Larson, Jianxiang Wang, Dong-Wook Kim, Dennis Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Inho Kim, Gabriel Etienne, Shruti Kapoor, Rajendra Jinwal, Kamel Malek, Lillian Yau, Timothy Hughes, Naoto Takahashi
Journal: Blood
Blood (2025) 146 (Supplement 1): 1997.
https://doi.org/10.1182/blood-2025-1997
Published: 2025
Journal Articles

Living the recovery: One-year qol outcomes for patients receiving ptcy gvhd prophylaxis on the access clinical trial

Free
Rachel Cusatis, Jianqun Kou, Juan (Maggie) Wu, Caitrin Bupp, Deborah Mattila, Sarah Smith, Kathryn Flynn, Jeffery Auletta, Steven Devine, Brent Logan, Bronwen Shaw
Journal: Blood
Blood (2025) 146 (Supplement 1): 6042.
https://doi.org/10.1182/blood-2025-6042
Published: 2025
Journal Articles

Improved long-term tolerability with asciminib (ASC) vs investigator-selected (IS) tyrosine kinase inhibitors (TKIs) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): Week 96 exploratory analysis of the phase 3 ASC4FIRST trial

Free
Timothy Hughes, Jorge Cortes, Jennifer Vaughn, Kathryn Flynn, Naoto Takahashi, Ghayas Issa, Felice Bombaci, Jianxiang Wang, Dong-Wook Kim, Dennis Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Inho Kim, Gabriel Etienne, Rajendra Jinwal, Andrea Damon, David Wei, Gabriel Marquez, Ennan Gu, Gopi Madhav Bommidi, Andreas Hochhaus, Richard Larson
Journal: Blood
Blood (2025) 146 (Supplement 1): 5549.
https://doi.org/10.1182/blood-2025-5549
Published: 2025
Journal Articles

The humanistic burden of patients with chronic myeloid leukemia (CML) treated with first line (1L) tyrosine kinase inhibitors (TKIs)

Free
Kelly Schoenbeck, Joan Clements, Karen Demairo, David Wei, Nisha Hazra, Cristina Constantinescu, Yan Meng, Dominick Latremouille-Viau, Gabriel Marquez, Daisy Yang, Andrea Damon, Islam Mohamad Sadek, Annie Guerin, Kathryn Flynn
Journal: Blood
Blood (2025) 146 (Supplement 1): 6388.
https://doi.org/10.1182/blood-2025-6388
Published: 2025
Journal Articles

Results from the U.S. Life after Stopping TKIs (LAST) Study

Free
Ehab Atallah, MD, Charles A. Schiffer, MD, Jerald P. Radich, MD, Kevin Weinfurt, PhD, Mei-Jie Zhang, PhD, Vamsi Kota, MBBS, Javier Pinilla-Ibarz, MD PhD, Joseph O. Moore, MD, Richard A. Larson, MD, Vivian Oehler, MD, Michael J. Mauro, MD, Michael W. Deininger, MD PhD, James E. Thompson, MD, Neil P. Shah, MD PhD, Martha Wadleigh, MD, Ellen K Ritchie, MD, Richard T Silver, MD, Jorge E. Cortes, MD, Arielle Baim, Mary M. Horowitz, MD MS, Kathryn Flynn, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2903.
https://doi.org/10.1182/blood.V130.Suppl_1.2903.2903
Published: 2017
Journal Articles

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Free
Anita D'Souza, MBBS, Heather R. Millard, MPH, Jennifer Knight, MD, Ruta Brazauskas, PhD, Jenny Vogel, Deborah Mattila, Kathryn Flynn, PhD, Stephanie J Lee, MD MPH, Mary M. Horowitz, MD MS, J. Douglas Rizzo, MD, Bronwen E. Shaw, PhD MRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 3447.
https://doi.org/10.1182/blood.V130.Suppl_1.3447.3447
Published: 2017